Skip to main content
  • Register
  • Help
  • Contact us

Creo Medical Group Plc (CREO) Ord GBP0.001

Sell:200.00p Buy:210.00p 0 Change: No change
FTSE AIM 100:0.09%
Market closed Prices as at close on 23 April 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:200.00p
Buy:210.00p
Change: No change
Market closed Prices as at close on 23 April 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:200.00p
Buy:210.00p
Change: No change
Market closed Prices as at close on 23 April 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Creo Medical Group plc is a United Kingdom-based medical device company. The Company focuses on the field of surgical endoscopy. The Company focuses on the development and commercialization of minimally invasive surgical devices, initially in the area of gastrointestinal (GI) surgery and lung cancer. The Company has developed CROMA, which is an electrosurgical platform that can deliver microwave and bipolar radiofrequency through a single accessory port. The Company's surgical system CROMA combines bipolar radiofrequency for localized cutting and microwave energy for controlled coagulation, which provides physicians with simplified and controlled surgical solutions. The Company's pipeline portfolio of instruments is targeted at three therapeutic endoscopic specialties: lower GI; lung/bronchoscopy and upper GI.

Contact details

Address:
Unit 2 Beaufort Park,, Beaufort Park Way
CHEPSTOW
NP16 5UH
United Kingdom
Telephone:
+44 (01291) 606005
Website:
https://creomedical.com/

Important dates

Future events
There are no future events available.
Past events
Trading Announcement 17 February 2021 17/02/21
Interim results 23 September 2020 23/09/20
AGM 24 June 2020 24/06/20
Annual report 27 May 2020 27/05/20
Final results 07 May 2020 07/05/20

General stock information

EPIC:
CREO
ISIN:
GB00BZ1BLL44
Market cap:
£331.57 million
Shares in issue:
157.89 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE AIM 100,FTSE AIM All Share

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.